Potent antibody-based conjugates for cancer therapy: From early stage research to a clinically approved drug

Date 02 March 2015
Event 13th International Congress on Targeted Anticancer Therapies
Session New drugs and targets in hematological malignancies
Topics Anti-Cancer Agents & Biologic Therapy
Drug Development
Haematologic Malignancies
Presenter Peter Senter